Skip to main content
. 2019 Feb 25;10:240. doi: 10.3389/fimmu.2019.00240

Figure 6.

Figure 6

Effect of PTX3 on AP activity in vitro. The effect of recombinant human PTX3 on AP hemolytic activity (A) and AP-mediated C9 deposition (B) is shown in percent compared to buffer control added to pooled serum of healthy individuals. Data represent mean of 3 times repeated experiments with technical duplicates, error bars indicate the standard error of mean. Statistical analysis was performed with the Kruskal-Wallis test corrected for multiple comparisons using the Dunn's post hoc test. Statistical significance is indicated by asterisks (*p < 0.05; ***p < 0.001). AP, alternative pathway; PTX3, pentraxin-3.